Comparison of Carotenoid Bioavailability From Fresh Papaya, Tomato and Carrot

Sponsor
Ohio State University (Other)
Overall Status
Completed
CT.gov ID
NCT01748916
Collaborator
University of Hohenheim (Other), Universidad de Costa Rica (Other)
16
2
6
5
8
1.6

Study Details

Study Description

Brief Summary

The goal of this study is to determine if papaya fruits are an exceptionally good food source for carotenoids in humans, particularly when compared more common carotenoid sources like carrots and tomatoes. This objective will be accomplished by quantitation of the immediate post-prandial plasma concentrations of parent carotenoids and vitamin A metabolites from subjects who consumed a meal containing fresh papaya, tomato, and carrot.

Condition or Disease Intervention/Treatment Phase
  • Other: Papaya
  • Other: Carrot
  • Other: Tomato
N/A

Detailed Description

The main purpose of this study is comparing bioavailability of papaya carotenoids versus carrot and tomato carotenoids. Previously, vitamin A deposition in rat livers was studied, showing that carotenoid bioavailability from papaya is higher than from spinach, parsley and carrots. Detailed knowledge about human carotenoid absorption and conversion from papaya fruit compared to other food sources is still lacking.

Study Design

Study Type:
Interventional
Actual Enrollment :
16 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Evaluation of the Effect of the Consumption of Papaya, Tomato, and Carrot on the Bioavailability of Carotenoids
Study Start Date :
Jun 1, 2011
Actual Primary Completion Date :
Nov 1, 2011
Actual Study Completion Date :
Nov 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Papaya-Carrot-Tomato

Test meals were consumed in the following order: 1. Papaya 2. Carrot 3. Tomato.

Other: Papaya
Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Other: Carrot
Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Other: Tomato
Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Experimental: Papaya-Tomato-Carrot

Test meals were consumed in the following order: 1. Papaya 2. Tomato 3. Carrot

Other: Papaya
Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Other: Carrot
Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Other: Tomato
Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Experimental: Tomato-Papaya-Carrot

Test meals were consumed in the following order: 1. Tomato 2. Papaya 3. Carrot

Other: Papaya
Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Other: Carrot
Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Other: Tomato
Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Experimental: Tomato-Carrot-Papaya

Test meals were consumed in the following order: 1. Tomato 2. Carrot 3. Papaya

Other: Papaya
Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Other: Carrot
Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Other: Tomato
Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Experimental: Carrot-Papaya-Tomato

Test meals were consumed in the following order: 1. Carrot 2. Papaya 3. Tomato

Other: Papaya
Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Other: Carrot
Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Other: Tomato
Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Experimental: Carrot-Tomato-Papaya

Test meals were consumed in the following order: 1. Carrot 2. Tomato 3. Papaya

Other: Papaya
Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Other: Carrot
Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Other: Tomato
Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.

Outcome Measures

Primary Outcome Measures

  1. Pharmacokinetics of Carotenoid Absorption From Papaya, Carrot and Tomato [8 post-prandial blood samples over 9.5 hours]

    The primary goal of this research is to investigate whether papaya can deliver increased quantities of carotenoids when compared to carrot and tomato. An area under the curve for concentration of carotenoids (from triglyceride rich lipoprotein (TRL) fraction of plasma) over time will be determined to quantify absorption, after subjects consume a meal containing papaya, carrot or tomato.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy individuals
Exclusion Criteria:
  • lactating, pregnant, or planned to be pregnant

  • smokers/those who use tobacco products

  • metabolic or malabsorption disorders

  • had a history of cancer

  • history of liver insufficiency or other gastro-intestinal diseases

  • allergy to papaya, carrots or tomatoes

  • obesity

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Ohio State University Columbus Ohio United States 43210
2 University of Costa Rica San José Costa Rica

Sponsors and Collaborators

  • Ohio State University
  • University of Hohenheim
  • Universidad de Costa Rica

Investigators

  • Principal Investigator: Steven J Schwartz, Ph.D., Ohio State University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jessica Cooperstone, Research Scientist, Ohio State University
ClinicalTrials.gov Identifier:
NCT01748916
Other Study ID Numbers:
  • 2011H0336
First Posted:
Dec 13, 2012
Last Update Posted:
Jul 9, 2021
Last Verified:
Jul 1, 2021
Keywords provided by Jessica Cooperstone, Research Scientist, Ohio State University

Study Results

Participant Flow

Recruitment Details Recruitment was carried out at the University of Costa Rica during June 2011 - August 2011.
Pre-assignment Detail Sixteen healthy, non-pregnant, non-smoking participants (21-44 y) were enrolled after checking eligibility, which was based on a questionnaire. Exclusion criteria included any history of chronic gastrointestinal disease, use of medications affecting lipid metabolism, regular use of carotenoid-containing supplements and frequent alcohol consumption.
Arm/Group Title Papaya-Carrot-Tomato Papaya-Tomato-Carrot Tomato-Papaya-Carrot Tomato-Carrot-Papaya Carrot-Papaya-Tomato Carrot-Tomato-Papaya
Arm/Group Description Test meals were consumed in the following order: 1. Papaya 2. Carrot 3. Tomato. Papaya: Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread. Carrot: Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread. Tomato: Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread. Test meals were consumed in the following order: 1. Papaya 2. Tomato 3. Carrot Papaya: Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread. Carrot: Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread. Tomato: Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread. Test meals were consumed in the following order: 1. Tomato 2. Papaya 3. Carrot Papaya: Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread. Carrot: Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread. Tomato: Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread. Test meals were consumed in the following order: 1. Tomato 2. Carrot 3. Papaya Papaya: Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread. Carrot: Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread. Tomato: Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread. Test meals were consumed in the following order: 1. Carrot 2. Papaya 3. Tomato Papaya: Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread. Carrot: Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread. Tomato: Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread. Test meals were consumed in the following order: 1. Carrot 2. Tomato 3. Papaya Papaya: Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread. Carrot: Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread. Tomato: Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.
Period Title: Overall Study
STARTED 2 3 2 3 3 3
COMPLETED 2 3 2 3 3 3
NOT COMPLETED 0 0 0 0 0 0

Baseline Characteristics

Arm/Group Title All Groups (Average)
Arm/Group Description All study participants
Overall Participants 16
Age (years) [Median (Full Range) ]
Median (Full Range) [years]
27
Age (Count of Participants)
<=18 years
0
0%
Between 18 and 65 years
16
100%
>=65 years
0
0%
Sex: Female, Male (Count of Participants)
Female
10
62.5%
Male
6
37.5%
Region of Enrollment (participants) [Number]
Costa Rica
16
100%

Outcome Measures

1. Primary Outcome
Title Pharmacokinetics of Carotenoid Absorption From Papaya, Carrot and Tomato
Description The primary goal of this research is to investigate whether papaya can deliver increased quantities of carotenoids when compared to carrot and tomato. An area under the curve for concentration of carotenoids (from triglyceride rich lipoprotein (TRL) fraction of plasma) over time will be determined to quantify absorption, after subjects consume a meal containing papaya, carrot or tomato.
Time Frame 8 post-prandial blood samples over 9.5 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Beta-Carotene Absorption From Papaya Beta-Carotene Absorption From Tomato Beta-Carotene Absorption From Carrot Lycopene Absorption From Papaya Lycopene Absorption From Tomato
Arm/Group Description
Measure Participants 16 16 16 16 16
Median (Inter-Quartile Range) [nmol*h/L]
163
62
64
174
58

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title All Groups
Arm/Group Description All groups in study
All Cause Mortality
All Groups
Affected / at Risk (%) # Events
Total / (NaN)
Serious Adverse Events
All Groups
Affected / at Risk (%) # Events
Total 0/16 (0%)
Other (Not Including Serious) Adverse Events
All Groups
Affected / at Risk (%) # Events
Total 0/16 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Ralf Schweiggert
Organization University of Hohenheim
Phone 0049-711-459-22995
Email ralf.schweiggert@uni-hohenheim.de
Responsible Party:
Jessica Cooperstone, Research Scientist, Ohio State University
ClinicalTrials.gov Identifier:
NCT01748916
Other Study ID Numbers:
  • 2011H0336
First Posted:
Dec 13, 2012
Last Update Posted:
Jul 9, 2021
Last Verified:
Jul 1, 2021